Blood pressure numbers: what the stages mean
Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
The categories look like a simple table and are more useful once you know what each one is for: one set of numbers defines the diagnosis, a different set applies at home, and a third decides the treatment target.
The threshold that most people remember, 140/90, was lowered to 130/80 in the United States in 2017, which reclassified a very large number of people overnight.
Related pages: High blood pressure (hypertension)
The bottom line
- Hypertension is defined as 130/80 mmHg or higher in current US guidelines.
- Home and ambulatory readings use lower thresholds than clinic readings.
- White-coat and masked hypertension are both common and have different consequences.
- Intensive lowering reduced cardiovascular events in high-risk adults in the SPRINT trial.
- Whether the 130/80 threshold is right for everyone, which guidelines outside the US treat differently.
- The best target in the very elderly and frail, where the balance shifts.
The story, step by step
- 1. The map ()
- 2. The change ()
- 3. Different places, different numbers ()
- 4. White coat and masked ()
- 5. Targets ()
What the evidence labels mean
Normal to crisis
What happens
The categories, in order.
What the research shows
- Normal: less than 120 systolic and less than 80 diastolic. Both conditions have to be met.
- Elevated: 120 to 129 systolic and less than 80 diastolic. Not a disease, and a warning that is worth acting on with lifestyle measures.
- Stage 1 hypertension: 130 to 139 systolic or 80 to 89 diastolic.
- Stage 2 hypertension: 140 or higher systolic, or 90 or higher diastolic.
- Hypertensive crisis: higher than 180 systolic and/or higher than 120 diastolic. This needs prompt action, and what kind depends on symptoms.
- When the two numbers fall in different categories, the higher category applies. 128/92 is stage 1 hypertension, not elevated.
- Isolated systolic hypertension, a high top number with a normal bottom number, is the commonest pattern in older adults and is treated rather than dismissed.
Why it matters
The common mistake is reading only the top number. The rule is that the worse of the two decides.
What's still uncertain
- Whether stage 1 by diastolic alone carries the same risk as by systolic alone at older ages.
Read more
- NHLBI: High blood pressureGovernment
- CDC: High blood pressureGovernment
- American Heart Association: hypertension guideline resourcesNonprofit
Next: The change
Why the threshold moved
What happens
What happened in 2017 and why it mattered.
What the research shows
- Until 2017, hypertension in the United States began at 140/90. The ACC/AHA guideline moved stage 1 to 130/80.
- The reasoning was that risk rises continuously from well below 140/90, and that people in the 130s were accumulating damage while being told they were fine.
- The practical effect was large: the proportion of US adults classified as hypertensive rose to nearly half.
- It did not mean that everyone newly reclassified needed medicine. For most people with stage 1 and low overall cardiovascular risk, the recommendation is lifestyle change with reassessment.
- Medicine is recommended at stage 1 for people who already have cardiovascular disease, diabetes, chronic kidney disease, or a high calculated ten-year risk, and for everyone at stage 2.
- Several guidelines outside the United States kept 140/90 as the treatment threshold for lower-risk people, so a person can be hypertensive by one guideline and not another. Both are defensible readings of the same evidence.
Why it matters
A new diagnosis under this threshold often means lifestyle change and watching, rather than tablets, and that distinction gets lost.
What's still uncertain
- Which threshold produces the best balance of benefit and overtreatment, which remains genuinely debated.
Read more
Home, clinic and 24-hour
What happens
Why the same person has three sets of numbers.
What the research shows
- Clinic readings run higher than home readings for most people, which is why out-of-office measurement is now recommended to confirm a diagnosis.
- For home monitoring, the equivalent of a clinic 130/80 is an average home reading of 130/80 or above, based on a week of twice-daily readings.
- Ambulatory monitoring, a cuff worn for 24 hours, uses lower thresholds again: a daytime average of 130/80, a 24-hour average of 125/75, and a night-time average of 110/65.
- Blood pressure normally falls by 10 to 20 percent during sleep. People whose pressure does not fall, called non-dippers, have higher cardiovascular risk, and night-time pressure is the single best predictor of outcome.
- Only ambulatory monitoring measures night-time pressure, which is one reason it is used despite being less convenient.
- A single clinic reading, however alarming, is not a diagnosis.
Why it matters
Comparing a home reading against a clinic threshold is the most common way people frighten themselves or falsely reassure themselves.
What's still uncertain
- How best to use night-time readings in treatment decisions, which is an active question.
Read more
- CDC: Measure your blood pressureGovernment
- MedlinePlus: How to measure blood pressure at homeGovernment
- USPSTF: Screening for hypertension in adultsGovernment
Next: White coat and masked
When the setting changes the number
What happens
Two common patterns with opposite implications.
What the research shows
- White-coat hypertension is high in clinic and normal out of it. It affects a substantial minority and is not entirely benign, since some of these people go on to develop sustained hypertension, but it generally does not need treatment.
- Masked hypertension is the reverse: normal in clinic and high at home or over 24 hours. It carries risk similar to sustained hypertension and is missed entirely by clinic measurement alone.
- Masked hypertension is more common in younger people, men, smokers, people who drink heavily, those with diabetes or kidney disease, and people under work stress.
- This is the strongest single argument for home monitoring: clinic readings alone miss a whole group of people at real risk.
- There is also white-coat effect in people already diagnosed, where clinic readings overstate control and lead to over-treatment.
- If home and clinic readings disagree consistently, that difference is information rather than an error, and it is worth raising rather than assuming one device is wrong.
Why it matters
Masked hypertension is the reason a normal reading at the doctor is not the end of the question for people with risk factors.
What's still uncertain
- How often white-coat hypertension progresses to sustained hypertension.
Read more
- USPSTF: Screening for hypertension in adultsGovernment
- CDC: Measure your blood pressureGovernment
- American Heart Association: hypertension guideline resourcesNonprofit
Next: Targets
How low, and for whom
What happens
What treatment aims at.
What the research shows
- Current US guidance sets a general target of below 130/80 for most adults on treatment.
- The SPRINT trial compared a systolic target below 120 with below 140 in adults at high cardiovascular risk without diabetes. The intensive group had fewer cardiovascular events and fewer deaths, and the trial was stopped early.
- SPRINT also measured blood pressure in a careful, unattended way that produces lower numbers than a typical clinic reading, which is part of why translating its target into practice is argued about.
- The intensive group had more low blood pressure episodes, fainting and kidney function changes, so the benefit came with real costs.
- In older and frailer adults the balance shifts. Standing blood pressure should be checked, because orthostatic drops cause falls, and falls in this group cause more harm than a slightly higher reading.
- Targets differ for specific groups, including people with diabetes, chronic kidney disease and previous stroke, and for pregnancy, which has its own rules entirely.
- The right target is a conversation rather than a universal number, and asking what yours is and why is reasonable.
Why it matters
Lower is generally better up to a point, and the point differs by person, which is why one number for everyone was never going to work.
What's still uncertain
- The optimal target in people over 80 and in frailty, where trials under-represent the people being treated.